Nasdaq:US$15.99 (+0.35) | HKEX:HK$24.75 (+0.65) | AIM:£2.49 (+0.01)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 4 Jul 2006

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate

1 items
a060704